Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for Untreated Severe Obstructive Sleep Apnoea/Hypopnoea Syndrome: A Simulated Cost-Utility Analysis from a National Health Service Perspective.

Deirdre B BlissettJoerg S SteierYakubu G KaragamaRob S Blissett

Published in: PharmacoEconomics - open (2021)

Over a patient's lifetime, HNS with Inspire is expected to be cost effective when compared with no treatment in patients with severe OSAHS who have tried and have not responded to CPAP, from an NHS perspective.

Keyphrases

case report
positive airway pressure
early onset
obstructive sleep apnea
patient safety
quality improvement
sleep apnea
drug induced
sleep quality
combination therapy
depressive symptoms
data analysis